Page last updated: 2024-11-02

4-phenylbutyric acid and Colorectal Cancer

4-phenylbutyric acid has been researched along with Colorectal Cancer in 2 studies

4-phenylbutyric acid: RN refers to the parent cpd
4-phenylbutyric acid : A monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, L1
Ma, L1
Liu, C1
Lei, Y1
Tang, N1
Huang, Y1
Huang, G1
Li, D1
Wang, Q1
Liu, G1
Tang, M1
Jing, Z1
Deng, Y1
Tanaka, T1
Kojima, K1
Yokota, K1
Tanaka, Y1
Ooizumi, Y1
Ishii, S1
Nishizawa, N1
Yokoi, K1
Ushiku, H1
Kikuchi, M1
Kojo, K1
Minatani, N1
Katoh, H1
Sato, T1
Nakamura, T1
Sawanobori, M1
Watanabe, M1
Yamashita, K1

Other Studies

2 other studies available for 4-phenylbutyric acid and Colorectal Cancer

ArticleYear
ERp29 counteracts the suppression of malignancy mediated by endoplasmic reticulum stress and promotes the metastasis of colorectal cancer.
    Oncology reports, 2019, Volume: 41, Issue:3

    Topics: Animals; Colorectal Neoplasms; Cullin Proteins; Culture Media, Conditioned; Endoplasmic Reticulum St

2019
Comprehensive Genetic Search to Clarify the Molecular Mechanism of Drug Resistance Identifies ASCL2-LEF1/TSPAN8 Axis in Colorectal Cancer.
    Annals of surgical oncology, 2019, Volume: 26, Issue:5

    Topics: Antineoplastic Agents; Basic Helix-Loop-Helix Transcription Factors; Biomarkers, Tumor; Colorectal N

2019